- Home
- SNY vs APH Comparison
SNY vs APH Comparison
Compare SNY & APH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- APH
- Stock Information
- Founded
- SNY 1994
- APH 1932
- Country
- SNY France
- APH United States
- Employees
- SNY N/A
- APH N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- APH Electrical Products
- Sector
- SNY Health Care
- APH Technology
- Exchange
- SNY Nasdaq
- APH Nasdaq
- Market Cap
- SNY 116.5B
- APH 113.0B
- IPO Year
- SNY N/A
- APH 1991
- Fundamental
- Price
- SNY $48.61
- APH $98.86
- Analyst Decision
- SNY Buy
- APH Buy
- Analyst Count
- SNY 2
- APH 11
- Target Price
- SNY $62.50
- APH $89.91
- AVG Volume (30 Days)
- SNY 2.2M
- APH 9.0M
- Earning Date
- SNY 07-31-2025
- APH 07-23-2025
- Dividend Yield
- SNY 3.29%
- APH 0.67%
- EPS Growth
- SNY 39.56
- APH 25.95
- EPS
- SNY 5.45
- APH 2.06
- Revenue
- SNY $48,817,552,946.00
- APH $16,777,400,000.00
- Revenue This Year
- SNY $3.39
- APH $34.58
- Revenue Next Year
- SNY $7.05
- APH $8.09
- P/E Ratio
- SNY $8.92
- APH $47.95
- Revenue Growth
- SNY N/A
- APH 30.70
- 52 Week Low
- SNY $45.80
- APH $54.77
- 52 Week High
- SNY $60.12
- APH $99.99
- Technical
- Relative Strength Index (RSI)
- SNY 46.26
- APH 67.95
- Support Level
- SNY $47.99
- APH $97.13
- Resistance Level
- SNY $49.43
- APH $99.99
- Average True Range (ATR)
- SNY 0.58
- APH 1.71
- MACD
- SNY 0.18
- APH -0.34
- Stochastic Oscillator
- SNY 56.15
- APH 81.46
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About APH Amphenol Corporation
Amphenol is a global supplier of connectors, sensors, and interconnect systems. Amphenol holds the second-largest connector market share globally and sells into the end markets of automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks. Amphenol is diversified geographically, with operations in 40 countries.